## LHX: L3Harris Technologies, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 1.1% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($285.01)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. L3Harris Technologies Inc $LHX Shares Sold by Norris Perne & French LLP MI**
- Source: MarketBeat | 20251229T123018 | Somewhat-Bullish | Relevance: 100%
- Norris Perne & French LLP MI significantly reduced its stake in L3Harris Technologies Inc (NYSE:LHX) by 61.2% in the third quarter, selling 42,547 shares and holding 26,930 shares valued at $8.225 million. CEO Christopher E. Kubasik also sold a substantial number of shares, reducing his position by nearly 9%. Despite these sales, L3Harris Technologies exceeded Q3 earnings estimates and maintains a "Moderate Buy" consensus rating from analysts with an average target price of $295.50.

**2. HM Payson & Co. Has $133.59 Million Stock Position in L3Harris Technologies Inc $LHX**
- Source: MarketBeat | 20251229T120753 | Somewhat-Bullish | Relevance: 100%
- HM Payson & Co. reduced its stake in L3Harris Technologies Inc (NYSE:LHX) by 19.1% in the third quarter, now holding 437,410 shares valued at $133.59 million. L3Harris reported strong Q3 earnings, surpassing analyst estimates, and announced a quarterly dividend of $1.20 per share. The company maintains a "Moderate Buy" consensus rating from analysts with an average target price of $295.50.

**3. Trading the Move, Not the Narrative: (LHX) Edition**
- Source: Stock Traders Daily | 20251228T203400 | Bullish | Relevance: 96%
- This article provides a detailed analysis of L3Harris Technologies Inc. (NYSE: LHX), highlighting strong sentiment across all horizons and an exceptional 20.4:1 risk-reward short setup. It outlines specific institutional trading strategies, including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis and AI-generated signals for LHX.

**4. The New Iron Dome: Why Billions Are Flowing Into Space & Counter-Drone Tech**
- Source: The Globe and Mail | 20251229T160753 | Bullish | Relevance: 92%
- Billions are being invested in space and counter-drone technologies as global threats from hostile drones and hypersonic missiles accelerate. This article highlights several companies, including VisionWave Holdings Inc., Rocket Lab Corporation, L3Harris Technologies, AeroVironment, Inc., and BigBear.ai, that are at the forefront of this rapidly expanding defense technology market. These companies are developing advanced solutions ranging from missile tracking satellites and autonomous robotics to laser weapon systems and AI-driven threat detection platforms to address modern warfare challenges.

**5. The New Iron Dome: Why Billions Are Flowing Into Space & Counter-Drone Tech**
- Source: GlobeNewswire | 20251229T154025 | Bullish | Relevance: 80%
- Billions are being invested in space and counter-drone technology, driven by increasing threats from hostile drones and the need for advanced missile tracking systems. The counter-unmanned aircraft system market is projected to reach $20.31 billion by 2030, and the military unmanned systems market is expected to hit $76.05 billion by 2035. Companies like VisionWave Holdings Inc. (NASDAQ: VWAV), Rocket Lab Corporation (NASDAQ: RKLB), L3Harris Technologies (NYSE: LHX), AeroVironment, Inc. (NASDAQ: AVAV), and BigBear.ai (NYSE: BBAI) are at the forefront of this technological surge, developing solutions ranging from missile tracking satellites and autonomous ground vehicles to advanced AI-driven threat detection systems.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Morgan Stanley | $367 | $350 | +5% |
| 2025-12-12 | Citigroup | $331 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Morgan Stanley | up | Overweight |
| 2025-12-12 | Citigroup | init | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 6 ($2.46M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (+0.2%)
- Blackrock Inc.: 8.9% (-6.2%)
- Capital World Invest: 6.1% (-1.9%)
- State Street Corpora: 4.7% (-1.1%)
- Price (T.Rowe) Assoc: 3.2% (-30.7%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.56 indicates undervaluation relative to growth. Insider buying signal ($2.5M), management confidence. Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $55.4B |
| Beta | 0.66 |
| 52W Range | $193.09 - $308.12 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.56 |
| Forward P/E | 23.8 |
| Current P/E | 27.8 |
| YoY Growth | 16.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 2.6% to 1.1% (-1.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.9pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.86), confirming momentum. RSI neutral at 60. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.12% (CS: 88) | Neutral |
| RSI_14 | 59.6 | Neutral |
| MACD Histogram | 1.86 | Bullish |
| vs SMA20 | 1.037x | Above |
| vs SMA50 | 1.032x | Above |
| vs SMA200 | 1.135x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $296.03
- **Stop Loss:** $285.01 (3.7% risk)
- **Target:** $307.05 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 125
- **Position Value:** $37,003.75
- **Portfolio %:** 37.00%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite and defensive rotation. VIX at 14.2 (2nd percentile) signals low volatility, while positive yield curve (+58bps) and stable economic indicators support continued expansion. Market breadth at 58.7% shows decent participation, but rotation into defensive names and Fed liquidity concerns warrant measured positioning.*

### Earnings

**Next:** 2026-02-05 (Est: $2.77)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.57 | $2.70 | +5.1% |
| 2025Q2 | $2.50 | $2.78 | +11.3% |
| 2025Q1 | $2.32 | $2.41 | +4.0% |
| 2024Q4 | $3.42 | $3.47 | +1.5% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*